European Orthobiologics market is estimated to grow to around $1565.3 million by 2018


Posted September 30, 2014 by mmmwaterman

European Orthobiologics market is anticipated to spur due to rapidly aging population, and growing patient awareness

 
The European orthobiologics report defines and segments the concerned market in Europe with analysis and forecast of revenue. The orthobiologics market in Europe is estimated to grow to around $1565.3 million by 2018, at a developing CAGR of 6.6% from 2013 to 2018.

Browse through the TOC of the European orthobiologics market, to get an idea of the in-depth analysis provided. This also provides glimpse of orthobiologics market segmentation in the same region, and is supported by various tables and figures.

http://www.micromarketmonitor.com/market/europe-orthobiologics-9908210168.html

The demand for orthopedic care and procedures is rising in the elderly population, therefore, European market for orthopedic devices is expected to significantly benefit from the rise in the region’s aging population. All the product segments of orthobiologics like bone allograft, bone graft substitutes, bone growth factors & spinal stimulation, stem cell therapy, and viscosupplementation experienced a positive growth in 2013 with an increased demand for technological advances in bone graft materials.

This market will continue to witness high growth because of demand for innovative products and rise in prevalence of chronic arthritis, osteoarthritis and bone fracture, besides the aging population. Moreover, increase in obesity rate coupled with rise in demand for minimally invasive procedures has created a considerable demand for bone graft substitutes. In addition, technological advancements, growing patient awareness, rising incidences of road accidents and sport injuries have augmented the growth in this market.

This market is segmented and forecast on the basis of various types of products, namely, bone allograft, bone graft substitutes, bone growth factors & spinal stimulation, stem cell therapy, and viscosupplementation. The market is further segmented and forecast on the basis of major countries, such as the Germany, France, U.K., Italy, and Spain. The market is also segmented and analyzed further on the basis of the end users.

This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market.

About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MicroMarket Monitor
Country United States
Categories Health
Tags european orthobiologics market
Last Updated September 30, 2014